GW26-e3532 miR-433 Controls Cardiac Fibrosis  by Tao, Lichan & Li, Xinli
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C35stimulator, to create the tachycardia cardiomyopathy animal model,
and then to pace the right ventricle.
RESULTS After one week of right ventricular pacing, cardiac ultrasound
examination conﬁrmed the left ventricular end diastolic diameter
enlargement, reduction of left ventricular ejection fraction, increased
serum BNP and MMP-9, and decreased TIMP-1. Pathology of HE staining
showed myocardial structural derangement and interstitial inﬂamma-
tory cell inﬁltration. Electron microscopy revealed mitochondrial
swelling, dissolution, or even lysis and destruction, fuzzy Z line and
unclear intercalated discs. Three weeks later, the heart color, serum
BNP, MMP-9, TIMP-1, EF, FS in the rabbits recovered to former levels.
CONCLUSIONS Conclusions It is a simple and practical method to
establish an animal model of tachycardiomyopathy by stimulating
animal’s right ventricle with mapping electrode line to create non-
sustained ventricular tachycardia under minimally invasive, venous
technique without X-ray radiation.
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OBJECTIVES We aim to evaluate the possible association between
BDNF Val66Met polymorphism and common metabolic risks including
BMI, fasting blood glucose (FBG) and lipid levels in a longevous
population dwelling in Guangxi Hongshui River basin.
METHODS BDNF Val66Met was genotyped by ARMS-PCR technique
for 487 Zhuang long-lived inhabitants (aged  90, long-lived group,
LG), 593 offspring (age 60-77, offspring group, OG) and 582 matched
healthy controls (aged 60-75, control group, CG) in Hongshui River
Basin. Impacts of genotypes on metabolic risks were then evaluated.
RESULTS No signiﬁcant difference was noted on the distribution of
genotypic and allelic frequencies of BDNF Val66Met among the three
groups (all P > 0.05), regardless of sex; however, AA genotype was
dramatically higher in females than in males in the CG. The HDL-C
level of A genotype (GA/AA) carriers was signiﬁcantly lower than was
non-A genotype (GG) carriers in the overall population and the CG
(P ¼0.009 and 0.006, respectively), which remained in females, hy-
perglycemic subgroup and normolipidemic subgroup of CG through
stratiﬁcation of sex, BMI, glucose and lipid status. In addition, A ge-
notype carriers, with a higher systolic blood pressure, have 1.63 folds
higher risk than non-A carriers to become overweight in CG (95% CI :
1.05～2.55). Multiple regression analysis showed that the TC level of
LG was negatively correlated with BDNF Val66Met genotype.
CONCLUSIONS BDNF 66Met may lower the serum HDL-C level and
lead to overweight in the general population in Hongshui River area
but has less impact on the long-lived population and their offspring.
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OBJECTIVES Endoplasmic reticulum (ER) stress has become an
important therapeutic target for myocardial ischemia reperfusion (I/R)
injury. It has been reported that lycopene exhibits great pharmaco-
logical effect in alleviating myocardial I/R-injury, but whether it
attenuates ER stress remains to be elucidated. The purpose of this
study was to explore the potential protective beneﬁts of lycopene
against ER stress induced by hypoxia/reoxygenation in cultured
neonatal mouse cardiomyocytes.
METHODS Primary cultured neonatal C57BL/6 cardiomyocytes were
used to establish H/R model and divided to control, lycopene, H/R(4 h
hypoxia followed by 6 h reoxgenation) and lycopeneþH/R group (the
cardiomyocytes were pretreatment with 5mmol/L lycopene for 4 h
before H/R treatment). TUNEL assay was used to assess car-
diomyocytes apoptosis. Western blotting was used to evaluate the
expression of cleaved caspase-3, the level of phosphorylated eIF2a, a
downstream target of the PERK pathway and the expression of CHOP,
an ER stress-related apoptotic maker. The expression of GRP78 mRNAand level of the sliced Xbp-1 mRNA, a downstream target of the IRE1
pathway, were determined by Real-time PCR.
RESULTS The rate of TUNEL-positive cells signiﬁcantly increased to
25.622.61% and that of control and lycopene group were respectively
4.871.54% and 4.911.63% (P ＜0.01). After pretreatment with
lycopene, the rate decreased to 18.182.18% (P ＜0.05). Representa-
tive western blotting analysis and Quantitation of the Western blot-
ting by densitometric scanning showed approximately a 1.89-fold
increase in cleaved caspase-3 level (P ＜0.01), 1.84-fold increase in p-
eIF2a (P ＜0.05) and 1.98-fold increase in CHOP expression (P ＜0.01)
compared with the control group after H/R treatment. The cleaved
caspase-3 level decreased to 1.36-fold of normal levels (P ＜0.05), the
level of phosphorylated eIF2a reduced to 1.47-fold of normal levels (P
＜0.05) and the CHOP expression decreased to 1.54-fold of control
levels (P＜0.05) with lycopene pretreatment. Data from real-time PCR
displayed that H/R treatment induced a more than 4-fold increase in
the expression of GRP78 mRNA (P ＜0.01). Conversely, the mRNA
expression of GRP78 was signiﬁcantly attenuated to approximately 2-
fold of normal levels with 5 mM lycopene pretreatment (P ＜0.01), but
not completely come back the control levels. The level of the sliced
Xbp-1 mRNA had a 2.23-fold increase in H/R-treated cardiomyocytes
compared to control groups (P ＜0.01), in contrast, the level of the
sliced Xbp-1 mRNA was markedly downregulated to 1.20-fold of
control levels with 5 mM lycopene pretreatment (P ＜0.01), but not
completely come back the normal levels.
CONCLUSIONS The present study demonstrated that lycopene pro-
tects primary cultured neonatal mouse cardiomyocytes against H/R
injury by inhibiting the activation of the PERK and the IRE1 pathway
of the ER stress, the protective effect of lycopene on cardiomyocytes
highlights the therapeutic potential of plant-derived antioxidants
against I/R-injury.
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OBJECTIVES Vagal nerve stimulation (VNS) as a non-pharmacological
approach to retrieve the autonomic balance, has showed beneﬁcial
therapeutic effects for chronic heart failure (CHF). Moreover, calcium
cycling is critical in cardiac excitation-contraction coupling (ECC) and
participates in the antiarrhythmic effects of VNS. Taken together, we
hypothesized that VNS could improve the calcium handling properties
which might be underlying mechanisms of VNS for heart failure
treatment.
METHODS In this study, 32 SD rats were divided into three groups as
Control (sham operated), CHF-SS (CHF rats with sham stimulation)
and CHF-VNS (CHF rats with VNS). Cardiac function was evaluated by
echocardiography while the structural remodeling was assessed by HE
and Masson staining. ELISA was used to detect the plasma BNP,
norepinephrine and angiotensin II concentrations. The proteins and
mRNAs expression of sarcoplasmic reticulum Ca2þ ATPase (SER-
CA2a), phospholamban (PLB), ryanodine receptor 2 (RyR2), Naþ–Ca2þ
exchanger 1 (NCX1) were analyzed by Western blot and RT-PCR.
RESULTS Compared with CHF-SS rats, rats from CHF-VNS group
received 8 weeks of VNS showed signiﬁcantly improved left ventricular
ejection fraction (LVEF, P¼0.001) and less myocardial interstitial
collagen. The elevated plasma concentrations of BNP, norepinephrine
and Ang II in CHF rats were partially restored by VNS. After VNS, the rats
in CHF-VNS group exhibited statistically signiﬁcant higher cardiac SER-
CA2a protein and mRNA contents than CHF-SS group. RyR2 and
depressed PLB expressions were unaffected between rats with or without
VNS, whereas NCX1 expression was signiﬁcant lower in CHF-VNS group.
CONCLUSIONS The results suggest that the improvement of cardiac
performance by VNS is accompanied with reversal of changes in cal-
cium handling properties including SERCA2a, PLB and NCX1 which
may be underlying mechanisms of VNS for heart failure therapy.
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OBJECTIVES Cardiac ﬁbrosis, a result of multiple injurious insults in
heart, is a ﬁnal common manifestation of chronic heart diseases and
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participate in many essential biological processes and their dysfunc-
tion has been implicated in a variety of cardiovascular diseases
including ﬁbrosis. miR-433 has recently been implicated in renal
ﬁbrosis, however, its role in cardiac ﬁbrosis is unclear.
METHODS Cardiac ﬁbrosis were induced by TGF-b (10ng/ml, 24h)
and AngII (100nmol, 48h) on neonatal cardiac ﬁbroblasts. Quanti-
tative reverse transcription polymerase chain reactions (RT-PCRs),
immunoﬂuorescence and western blotting were used to determine
the expression levels of cardiac ﬁbrosis, includinga-SMA
and collagen. EdU and Ki-67 staining were used to evaluate cell
proliferation.
RESULTS miR-433 was increased in heart samples from dilated
cardiomyopathy patients. In addition, miR-433 was also consis-
tently upregulated in mice model of cardiac ﬁbrosis after myocar-
dial infarction or heart failure. Additionally, miR-433 was found to
be enriched in ﬁbroblasts compared to cardiomyocytes. In neonatal
cardiac ﬁbroblasts, forced expression of miR-433 promoted cell
proliferation as indicated by EdU and Ki-67 staining. Moreover,
miR-433 overexpression promoted the transdifferentiation of ﬁ-
broblasts into myoﬁbroblasts as determined for a-SMA and collagen
whether in the presence of TGF-b, AngII or not, indicating that
miR-433 is sufﬁcient to induce ﬁbrosis. In addition, knockdown of
miR-433 inhibited proliferation and the transdifferentiation into
myoﬁbroblasts, indicating that miR-433 is required for cardiac
ﬁbrosis. Interestingly, miR-433 did not affect the migration
of cardiac ﬁbroblast. Importantly, miR-433 antagomir could par-
tially attenuate cardiac ﬁbrosis induced by myocardial infarction
in mice.
CONCLUSIONS miR-433 controls cardiac ﬁbrosis both in vitro and in
vivo. Inhibition of miR-433 represents a novel therapeutic strategy
for cardiac ﬁbrosis.GW26-e3832
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OBJECTIVES The present study aimed to investigate the association
between potent rosuvastatin therapy and plaque mechanical stabili-
zation imaged by IVUSE.
METHODS 14 purebred New Zealand rabbits underwent a high-
cholesterol diet, then balloon-induced abdominal aorta endothelium
injury after 2 weeks. Seven rabbits received potent rosuvastatin
treatment for 8 weeks since the 13th week, while the seven other
rabbits took in saline. Intravascular ultrasound (IVUS) images of
abdominal aortas were acquired before and after the administration.
Each rabbit were chosen 2 obvious atherosclerotic plaques and 2
consecutive frames near the end-diastole images in situ were used to
construct an IVUS elastogram.
RESULTS Plaques in the rosuvastatin group demonstrated a stable
magnitude of sheer strain (SS) and area strain (AS) in the total plaque
(2.232.62% vs. 1.581.67%, p ¼ NS; 3.844.63% vs. 2.932.36%, p ¼
NS; respectively), but the untreated rabbits displayed a signiﬁcant
increase in the SS and AS index (1.911.05% vs. 3.541.73%,
p ¼0.005; 3.462.10% vs.5.952.59%, p ¼0.008; respectively). Dif-
ferences of the changes in SS and AS between the rosuvastatin and
control groups on serial follow-up were signiﬁcant (-0.992.83% vs.
1.151.96%, p ¼ 0.013; -1.675.05% vs. 1.252.29%, p ¼ 0.022;
respectively). SS and AS were negatively correlated with collagen
(r2 ¼ 0.341, p ¼0.001 and r2 ¼ 0.322, p ¼0.002, respectively)
and smooth muscle cell content (r2 ¼ 0.308, p ¼ 0.002 and r2 ¼
0.277, p ¼ 0.004, respectively) and positively with macrophage (r2 ¼
0.266, p ¼ 0.005 and r2 ¼ 0.198, p ¼ 0.018, respectively), lipid
content(r2 ¼ 0.388, p < 0.001 and r2 ¼ 0.357, p ¼ 0.001, respectively)
and vulnerability index (r2 ¼ 0.557, p < 0.001 and r2 ¼ 0.483, p <
0.001, respectively).
CONCLUSIONS These ﬁndings prove rosuvastatin therapy is associ-
ated with less vulnerable plaque features. IVUSE provides a technique
that may develop into a clinically available tool for detecting
vulnerable plaques and monitoring treatments.GW26-e3859
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OBJECTIVES Plasticity of vascular smooth muscle cells (VSMCs) plays
a central role in the onset and progression of proliferative vascular
diseases. In adult tissue, VSMCs exist in a physiological contractile-
quiescent phenotype, which is deﬁned by lack of the ability of pro-
liferation and migration, while high expression of contractile marker
proteins. After injury to the vessel, VSMC shifts from a contractile
phenotype to a pathological synthetic phenotype, associated with
increased proliferation, migration and matrix secretion. It has been
demonstrated that PDGF-BB is a critical mediator of VSMCs pheno-
typic switch. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-
3-methyl-glutaryl l coenzyme A (HMG-CoA) reductase, exhibits
various protective effects against VSMCs. In this study, we investi-
gated the effects of atorvastatin calcium on phenotype modulation
of PDGF-BB-induced VSMCs and the related intracellular signal
transduction pathways.
METHODS VSMCs were grown to 70–80% conﬂuence and pre-
cultured in serum-free medium for 24h before treatment. Atorvastatin
calcium was dissolved in methanol for a stock solution of 100mM and
then diluted to desired concentrations with media prior to cell treat-
ment. Cells were treated with various concentrations of atorvastatin
calcium from 1 to 50M in cell proliferation assay, 10M in cell
morphology and western blotting on quiescent cells with or without
20ng/mL PDGF-BB for designated times.
RESULTS Treatment of VSMCs with atorvastatin calcium showed
dose-dependent inhibition of PDGF-BB-induced proliferation. Ator-
vastatin calcium co-treatment inhibited the phenotype modulation
and cytoskeleton rearrangements and improved the expression of
contractile phenotype marker proteins such as a-SM actin, SM22a and
calponin in comparison with PDGF-BB alone stimulated VSMCs.
Although Akt phosphorylation was strongly elicited by PDGF-BB, Akt
activation was attenuated when PDGF-BB was co-administrated
with atorvastatin calcium.
CONCLUSIONS In conclusion, atorvastatin calcium inhibits pheno-
type modulation of PDGF-BB-induced VSMCs and activation of the
Akt signaling pathway, indicating that Akt might play a vital role
in the modulation of phenotype.
GW26-e4374
Tanshinone IIA Protects H9c2 Cells From Oxidative Stress-Induced Cell
Death Via Up-Regulation of MicroRNA-133 and Akt Activation
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OBJECTIVES In this study the cardioprotective effect and molecular
mechanisms of tanshinone IIA were investigated.
METHODS Cardiac H9c2 cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% fetal bovine serum. For
transfection experiments, cells were transfected with 50 nM miR-133
mimic or inhibitor; 8 hours later transfected cells were treated for 24
hours with various combination of H2O2 and tanshinone IIA as indi-
cated in ﬁgure legends. For inhibitor experiments, cells were pre-
incubated with selective PI3K inhibitor for 30 min, and then treated
with H2O2 and/or tanshinone IIA. Cell viability was determined by
CCK-8 kit. Data were presented as percentage of control. MiR-133
expression levels were relatively quantiﬁed by Bulge-Loop miRNA
qRT-PCR Primer Set in conjunction with real-time PCR with SYBR. The
relative expression of miR-133 was calculated and normalized to U6
using the comparative Ct method. Relative expression intensity
values were calculated as 2-DDCt. After treatment H9c2 cells were
harvested and lysed in RIPA lysis buffer (Applygen Technologies Inc.
Beijing, China). Then the whole cell lysates were resolved by 12%
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and transferred onto a 0.4 um-PVDF membrane. After
blocking in 5% nonfat milk for 2 h at room temperature, the PVDF
membranes were probed with primary antibody overnight.
Following a 30 minute wash, the membranes were incubated with
secondary antibody conjugated to HRP for 1 hour at room temper-
ature. The membranes were then washed for 30 minutes and
